NYSE: MRK

Merck & Co., Inc.

Healthcare | Drug Manufacturers - General

Market prices for MRK are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$1.25

Merck & Co., Inc. (NYSE: MRK) is a drug manufacturer. Figures from SEC EDGAR; updated 2026-10-18 13:43 UTC.

What Merck & Co., Inc. does

Merck is a global health care company operating two main business segments: Pharmaceutical and Animal Health. The Pharmaceutical segment produces prescription medicines, biologic therapies, and vaccines for human diseases, sold to drug wholesalers, retailers, hospitals, government agencies, and managed health care providers. The Animal Health segment develops and markets veterinary pharmaceutical products, vaccines, and health management solutions for livestock and companion animals, selling to veterinarians, distributors, farmers, and pet owners.

Summarized from Merck & Co., Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation	8-K 2026-10-13
EPS (TTM)	$1.25
Return on equity	34.70%
Debt/equity	1.29

Revenue Trend

Annual Revenue · Open in Platform →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-10-01

2026-10-01DirectorPhantom StockAward55$8.1K
2026-10-01DirectorPhantom StockAward206$30.0K
2026-10-01DirectorPhantom StockAward111$16.2K

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

BlackRock, Inc.226,999,837$29.17B+1.6%
VANGUARD CAPITAL MANAGEMENT LLC161,323,174$20.73B+0.2%
STATE STREET CORP120,413,256$15.57B+0.9%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2022-10-27Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2021-03-26Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2021-02-04Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

Merck Stock: Watch This Price, Prepare To Profit From This Trade
Yahoo2026-10-16POS
AbbVie vs. Merck: Which Pharma Stock Offers Better Value?
Yahoo2026-10-16
Merck’s Rally Reflects Renewed Confidence, but Has the Market Priced in Too Much?
Yahoo2026-10-16POS
Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success
STAT News2026-10-15
Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab
globenewswire.com2026-10-15

Questions this page answers

What does Merck & Co., Inc. do?

Merck is a global health care company operating two main business segments: Pharmaceutical and Animal Health.

When did MRK last file with the SEC?

Merck & Co., Inc.'s most recent SEC filing on record is a 8-K filed 2026-10-13. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-18 13:43 UTC. This page is also available as JSON at /api/data?ticker=MRK and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for MRK and 5,000+ tickers.

Create a free account — keep MRK

For your agent

GET /api/data?ticker=MRK

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt